Barnett, A.A. (1996), New obesity pill approved by FDA, LANCET, 347, 9011, 1321Barnett, A.A (1996), New obesity pill approved by FDA, The Lancet, 347, 9011, 1321Barnett, A.A (1996), New obesity pill approved by FDA, The Lancet , 347, 9011, 1321...
FDA approved Redux with just such a caveat, and when limited to these patients, the drugs may still make sense-despite the risks-because morbid obesity carries its own dangers, including heart disease, diabetes and stroke. Too often, however, Redux and fen-phen were peddled’’ to all ...
1Less than a year ago, a new generation of diet pills seemed to offer the long-sought answer to our chronic weight problems. Hundreds of thousands of pound-conscious Americans had discovered that a drug known as "fen-phen" could shut off huge appetites like magic, and the FDA had just ...
The Supreme Court issued a unanimous ruling preserving access to the abortion pill mifepristone on Thursday. The justices ruled that the group of anti-abortion rights doctors who sued the FDA did not have the legal grounds to do so. CBS News legal contributor Jessica Levinson breaks down the de...
Americans had discovered that a drug combination known as "fen-phen" could shut off voracious appetites pke magic, and the FDA had just approved a new drug, Redux, that did the same with fewer side effects. Redux would attract hundreds of thousands of new pill poppers within a few months...
Theuse of medication—rather than surgical procedures—to terminate pregnancy has risen steadily since the Food and Drug Administration (FDA) approved the abortion drug mifepristone in the United States in 2000, the Guttmacher Institute said.
While the FDA is not required to follow the advice of its clinical trials, it often does. The company expects to get a decision from the FDA by June 27. Lorqess is one of three weight-loss drugs vying to be the first new diet drug approved in a decade. ...
Consider the headline from STAT, “FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban.” True. Now the subhead, “The scrubbing could affect the ways researchers and companies test drugs and medical devices.” Key word, “could.” The great journal...
The scoop:In a span of three months, Chiesi gained FDA approval for two of its enzyme replacement therapies. The second came in May when the U.S. regulator signed off on Fabry disease drug Elfabrio. But in February, Lamzede wasapprovedas the first enzyme replacement therapy ...
Already approved in two indications in second line advanced kidney cancer, Ipsen charges £5,143 for a 30-day supply of the daily pill, although the manufacturer provides the drug at a confidential discount to the NHS under a private agreement. Sales of Cabometyx are mounting after approval ...